Navigation Links
Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery

Oct. 27 Event Kicks Off With Keynote by Investor and New England Patriots President Jonathan Kraft

Boston, MA (Vocus) September 30, 2009 -- The Boston biotechnology industry will get an early look at biotech's future value-drivers and newsmakers at the 2009 Boston Biotech R&D Conference on October 27, 2009 at Harvard Medical School.

At the one-day event, recently funded companies will present their science and platforms for the first time to a limited audience of 100 venture capitalists and pharmaceutical executives. The second annual conference will open with a keynote address by Jonathan Kraft, president of the New England Patriots, and president and chief executive officer of The Kraft Group, a group of privately held companies in professional sports, manufacturing and real estate investment.

"This will be an important gathering of the brightest minds in Boston's biotech research and development to shine a spotlight on their novel science and technology platforms," said Christoph Westphal, M.D., Ph.D., chief executive officer of Sirtris, a GSK company and senior vice president of the Center of Excellence for External Drug Discovery (CEEDD), GSK. "Thanks to the success of last year's inaugural R&D Conference, we received interest from biotech companies from across the country to participate in this year's conference, which reinforces Massachusetts' standing in the industry on a global scale."

Westphal founded the Boston Biotech Conference series four years ago, which includes the annual Boston Biotech Business Development Conference in April and Boston Biotech CEO Conference in June. In its second year, the R&D Conference is designed to showcase the next generation of leading biotech and pharmaceutical companies from the Boston area.

According to conference sponsor MassBio, the state continues to be a leader in the nation's biotech industry. With the number of Massachusetts residents working in the biotech industry at an all time high, companies in the state account for 6.4 percent of drugs in the pipeline globally, and next to California, Massachusetts is the best funded state for biotech venture capital investment.
"The Boston Biotech Conference series is one of the highlights of the year for our industry, as it offers an early look at the regional R&D success stories we are likely to read about in the upcoming year," said President & CEO of MassBio Robert K. Coughlin. "It's gatherings like these that help to spur the innovation and investment, which makes Massachusetts' biotechnology industry a global leader."

The 2009 Boston Biotech R&D Conference will highlight up-and-coming biotech companies in the Boston area. The agenda features several luminaries in medicine and research, as well as executives of the next generation of leading biotech and pharma companies from the Boston area. Jonathan Kraft president and chief executive officer of The Kraft Group and president of the New England Patriots, will provide the keynote address. The conference is being organized by Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris, a GSK company and Senior Vice President of the Center of Excellence for External Drug Discovery (CEEDD), GSK and Michelle Dipp, M.D., Ph.D., Vice President, Head of U.S. CEEDD, GSK. The conference is sponsored by Alexandria Real Estate Equities, Clinquest, MassBio, Massachusetts Life Sciences Center, Merriman Curhan Ford & Co. and Pure Communications, Inc. For more information or to register for the conference, visit


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is ... projects are designed, built and brought to market. , The Design Lab is ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
Breaking Biology News(10 mins):